These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 12466339)

  • 21. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA; Ribeiro SC
    Brain Res; 2006 Dec; 1126(1):148-55. PubMed ID: 16824495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors.
    Shankar RR; Jakacki RI; Haider A; Lee MW; Pescovitz OH
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1995-8. PubMed ID: 9177419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
    Golier JA; Schmeidler J; Yehuda R
    Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved single-dose metyrapone test.
    Dickstein G; Barzilai D
    Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy.
    Henley DE; Russell GM; Douthwaite JA; Wood SA; Buchanan F; Gibson R; Woltersdorf WW; Catterall JR; Lightman SL
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4234-42. PubMed ID: 19820009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Schmidt IL; Lahner H; Mann K; Petersenn S
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4193-8. PubMed ID: 12970286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.
    Farholt S; Sode-Carlsen R; Christiansen JS; Østergaard JR; Høybye C
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E173-80. PubMed ID: 20980432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ; Young EA; Andrew R; Seckl JR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
    de Lange WE; Sluiter WJ
    Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test.
    Tordjman K; Jaffe A; Trostanetsky Y; Greenman Y; Limor R; Stern N
    Clin Endocrinol (Oxf); 2000 May; 52(5):633-40. PubMed ID: 10792344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the dexamethasone-adrenocorticotropin test to assess the requirement for continued glucocorticoid replacement therapy after pituitary surgery.
    Beyer HS; Bantle JP; Mariash CN; Steffes MW; Seljeskog EL; Oppenheimer JH
    J Clin Endocrinol Metab; 1985 May; 60(5):1012-8. PubMed ID: 2984232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.
    Tordjman K; Jaffe A; Grazas N; Apter C; Stern N
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1301-5. PubMed ID: 7714104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests.
    Davidson JS; Bolland MJ; Croxson MS; Chiu W; Lewis JG
    Ann Clin Biochem; 2006 May; 43(Pt 3):237-9. PubMed ID: 16704764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism.
    Pang SY; Legido A; Levine LS; Temeck JW; New MI
    J Clin Endocrinol Metab; 1987 Aug; 65(2):282-9. PubMed ID: 3036902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis.
    Saltzman W; Hogan BK; Abbott DH
    Biol Psychiatry; 2006 Oct; 60(8):843-9. PubMed ID: 16499881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotropin secretory dynamics in humans under low glucocorticoid feedback.
    Veldhuis JD; Iranmanesh A; Naftolowitz D; Tatham N; Cassidy F; Carroll BJ
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5554-63. PubMed ID: 11701735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys
    Zöllner EW; Lombard CJ; Zemlin AE
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1272-1277. PubMed ID: 36062297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.